GR69314B - - Google Patents

Info

Publication number
GR69314B
GR69314B GR62524A GR800162524A GR69314B GR 69314 B GR69314 B GR 69314B GR 62524 A GR62524 A GR 62524A GR 800162524 A GR800162524 A GR 800162524A GR 69314 B GR69314 B GR 69314B
Authority
GR
Greece
Application number
GR62524A
Other languages
Greek (el)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of GR69314B publication Critical patent/GR69314B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GR62524A 1979-07-25 1980-07-23 GR69314B (cg-RX-API-DMAC10.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH689379 1979-07-25
AU66581/81A AU6658181A (en) 1979-07-25 1981-01-23 Increasing antibiotic action of antibiotics

Publications (1)

Publication Number Publication Date
GR69314B true GR69314B (cg-RX-API-DMAC10.html) 1982-05-14

Family

ID=34862371

Family Applications (1)

Application Number Title Priority Date Filing Date
GR62524A GR69314B (cg-RX-API-DMAC10.html) 1979-07-25 1980-07-23

Country Status (27)

Country Link
US (2) US4414204A (cg-RX-API-DMAC10.html)
EP (1) EP0025495B1 (cg-RX-API-DMAC10.html)
JP (1) JPS5649397A (cg-RX-API-DMAC10.html)
KR (1) KR840001617B1 (cg-RX-API-DMAC10.html)
AU (2) AU541147B2 (cg-RX-API-DMAC10.html)
CA (1) CA1183129A (cg-RX-API-DMAC10.html)
CS (1) CS276965B6 (cg-RX-API-DMAC10.html)
CY (1) CY1381A (cg-RX-API-DMAC10.html)
DD (1) DD153843A5 (cg-RX-API-DMAC10.html)
DE (1) DE3068304D1 (cg-RX-API-DMAC10.html)
DK (1) DK161025C (cg-RX-API-DMAC10.html)
ES (1) ES8105971A1 (cg-RX-API-DMAC10.html)
FI (1) FI75578C (cg-RX-API-DMAC10.html)
GR (1) GR69314B (cg-RX-API-DMAC10.html)
HK (1) HK85787A (cg-RX-API-DMAC10.html)
HU (1) HU188861B (cg-RX-API-DMAC10.html)
IE (1) IE50145B1 (cg-RX-API-DMAC10.html)
IL (1) IL60676A (cg-RX-API-DMAC10.html)
MX (1) MX9203368A (cg-RX-API-DMAC10.html)
MY (1) MY8700554A (cg-RX-API-DMAC10.html)
NO (1) NO157177C (cg-RX-API-DMAC10.html)
NZ (1) NZ194432A (cg-RX-API-DMAC10.html)
PL (2) PL127481B1 (cg-RX-API-DMAC10.html)
PT (1) PT71607A (cg-RX-API-DMAC10.html)
SG (1) SG38187G (cg-RX-API-DMAC10.html)
SU (2) SU1277905A3 (cg-RX-API-DMAC10.html)
ZA (1) ZA804487B (cg-RX-API-DMAC10.html)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582884A (en) * 1977-05-19 1981-01-14 Beecham Group Ltd Clavulanic acid derivatives their preparation and use
ZA804670B (en) * 1979-08-03 1981-07-29 Beecham Group Ltd Derivatives of clavulanic acid, a process for their preparation and their use
FI803077A7 (fi) * 1979-10-12 1981-04-13 Ciba Geigy Ag Foerfarande foer framstaellning av myramylpeptider
DE3169452D1 (en) * 1980-12-09 1985-04-25 Beecham Group Plc Derivatives of clavulanic acid, their preparation and their use
NZ199200A (en) * 1980-12-23 1984-07-31 Beecham Group Ltd Clavulanic acid derivatives and pharmaceutical compositions
EP0056560A1 (de) * 1981-01-19 1982-07-28 Ciba-Geigy Ag Antibiotische Präparate mit gesteigerter Wirksamkeit, Verfahren zu deren Herstellung und Verfahren zur Steigerung der antibiotischen Wirkung von Antibiotika
GR78246B (cg-RX-API-DMAC10.html) * 1981-01-23 1984-09-26 Ciba Geigy Ag
EP0102319B1 (de) * 1982-07-23 1987-08-19 Ciba-Geigy Ag Verwendung von Muramylpeptiden oder deren Analogen zur Prophylaxe und Therapie von Virusinfektionen
ATE23536T1 (de) * 1982-07-23 1986-11-15 Ciba Geigy Ag Neue muramylpeptide und verfahren zu ihrer herstellung.
US5189017A (en) * 1982-07-23 1993-02-23 Ciba-Geigy Corporation Use of sugar derivatives for the prophylaxis and treatment of virus infections
US5334583A (en) * 1982-07-23 1994-08-02 Ciba-Geigy Corp. Use of sugar derivatives for the prophylaxis and treatment of virus infections
US4746651A (en) * 1983-11-01 1988-05-24 Scripps Clinic And Research Foundation Antimicrobial chemotherapeutic potentiation using substituted nucleoside derivatives
US5171568A (en) * 1984-04-06 1992-12-15 Chiron Corporation Recombinant herpes simplex gb-gd vaccine
FR2564096B1 (fr) * 1984-05-11 1988-02-19 Anvar Derives lipophiles de muramylpeptides ayant des proprietes d'activation des macrophages, compositions les contenant et procede pour les obtenir
ATE45744T1 (de) * 1984-07-25 1989-09-15 Ciba Geigy Ag Phosphatidylverbindungen, verfahren zu ihrer herstellung und ihre verwendung.
US4885285A (en) * 1984-09-13 1989-12-05 Ciba-Geigy Corporation Phosphorus compounds, processes for their manufacture, and their use
CA1260393A (en) * 1984-10-16 1989-09-26 Lajos Tarcsay Liposomes of synthetic lipids
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
US4873322A (en) * 1986-01-24 1989-10-10 Ciba-Geigy Corporation Saccharide derivatives and processes for their manufacture
US4916118A (en) * 1986-08-18 1990-04-10 Board Of Regents, The University Of Texas System Pharmaceutical administration systems containing chemotactic peptides
US5149529A (en) * 1988-04-08 1992-09-22 Board Of Trustees Of Leland Chiron Corporation Compositions and treatment for herpes simplex
US5416070A (en) * 1988-07-08 1995-05-16 Immunotherapeutics, Inc. Composition for macrophage activation
US4950645A (en) * 1988-07-08 1990-08-21 Immunotherapeutics, Inc. Composition for macrophage activation
US4994440A (en) * 1989-02-13 1991-02-19 Creaven Patrick J Method for the treatment of renal cell carcinoma
GB9320820D0 (en) * 1993-10-08 1993-12-01 Biokine Tech Ltd Compounds for medicinal use
US6156319A (en) 1994-07-25 2000-12-05 The Trustees Of The University Of Pennsylvania Soluble herpesvirus glycoprotein complex vaccine
US6080427A (en) * 1997-04-17 2000-06-27 Bristol-Myers Squibb Company Cefadroxil monohydrate tablet formulation
AUPP059897A0 (en) * 1997-11-27 1998-01-08 Fujisawa Pharmaceutical Co., Ltd. New use of bicozamycin
US20040029842A1 (en) * 2001-12-18 2004-02-12 Gardner Wallace J. Triglyceride lowering, common cold and pneumonia prevention composition comprising tetracycline, and methods of treating or preventing diseases using same
AU2004262506A1 (en) 2003-02-28 2005-02-17 National Institutes Of Health Compositions, methods and kits relating to poxvirus subunit vaccines
US20050079187A1 (en) * 2003-10-14 2005-04-14 Gardner Wallace J. Composition, kit and method for reducing plaque formation, tooth decay and incidence of caries
EP1781338A4 (en) * 2004-07-19 2010-02-10 Baylor College Medicine MODULATION OF CYTOKIN SIGNALING REGULATORS AND APPLICATIONS FOR IMMUNOTHERAPY
CN101501055B (zh) * 2005-06-23 2016-05-11 贝勒医学院 负性免疫调节因子的调节和免疫疗法应用
EP2136832B1 (en) 2007-03-26 2015-09-02 General Regeneratives Limited Methods for promoting protection and regeneration of bone marrow using cxcl9 and anti-cxcl9 antibodies
WO2009082593A2 (en) * 2007-11-30 2009-07-02 Baylor College Of Medicine Dendritic cell vaccine compositions and uses of same
KR101730351B1 (ko) 2009-03-25 2017-04-28 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 병원체에 대한 포유동물의 선천성 면역 저항성의 자극을 위한 조성물
US9808504B2 (en) 2009-09-22 2017-11-07 Yale University Immunogenic epitopes as targets for universal cancer vaccines
JP6110377B2 (ja) 2011-07-12 2017-04-05 フィラデルフィア ヘルス アンド エデュケーション コーポレイション 新規クロストリジウム・ディフィシル（Ｃｌｏｓｔｒｉｄｉｕｍｄｉｆｆｉｃｉｌｅ）ＤＮＡワクチン
RU2491922C1 (ru) * 2012-04-26 2013-09-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Курская государственная сельскохозяйственная академия имени профессора И.И. Иванова Способ повышения биоцидного и лечебного действия крема-суспензии с энрофлоксацином
RU2527330C2 (ru) * 2012-07-05 2014-08-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Курская государственная сельскохозяйственная академия имени профессора И.И. Иванова Министерства сельского хозяйства Российской Федерации Способ повышения биоцидного и лечебного действия крема - суспензии с метронидазолом
WO2015116178A1 (en) 2014-01-31 2015-08-06 Thomas Jefferson University Fusion proteins for modulating regulatory and effector t cells
EP2951199A4 (en) 2013-01-31 2016-07-20 Univ Jefferson Fusion proteins for the modulation of regulatory and effector T cells
US10286065B2 (en) 2014-09-19 2019-05-14 Board Of Regents, The University Of Texas System Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
WO2016138286A1 (en) 2015-02-26 2016-09-01 Stc.Unm Irgm and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy
CN108883080B (zh) 2015-12-15 2021-12-21 巴拉特生物技术国际有限公司 胞壁酰肽衍生物化合物、其合成及其用途
JP7262100B2 (ja) 2016-04-29 2023-04-21 アイカーン スクール オブ メディスン アット マウント サイナイ 長期寛容を誘導するためのおよびアテローム性動脈硬化症におけるマクロファージ蓄積を解決するための自然免疫システムの標的化
WO2020140007A1 (en) 2018-12-28 2020-07-02 University Of Rochester Gene therapy for best1 dominant mutations
AU2022239614A1 (en) 2021-03-19 2023-10-12 Icahn School Of Medicine At Mount Sinai Compounds for regulating trained immunity, and their methods of use
WO2025096754A1 (en) 2023-10-31 2025-05-08 Musc Foundation For Research Development The use of enolase inhibitor pomhex for treatment of fibrosis
WO2026015821A1 (en) 2024-07-12 2026-01-15 University Of Rochester Antibiotic alkaloid and methods of generating and use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001395A (en) * 1972-06-20 1977-01-04 Agence Nationale De Valorisation De La Recherche (Anvar) Hydrosoluble extracts of mycobacteria
NL7308450A (cg-RX-API-DMAC10.html) * 1972-06-20 1973-12-27
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
CH613709A5 (en) 1975-12-10 1979-10-15 Ciba Geigy Ag Process for the preparation of glucosamine derivatives
US4082735A (en) * 1976-04-26 1978-04-04 Syntex (U.S.A.) Inc. Novel immunological adjuvant compounds and methods of preparation thereof
US4082736A (en) * 1976-04-26 1978-04-04 Syntex (U.S.A.) Inc. Novel immunological adjuvant compounds and methods of preparation thereof
GB1563561A (en) * 1976-06-23 1980-03-26 Daiichi Seiyaku Co Muramyldipeptide derivatives and process for the preparation thereof
FR2368282A1 (fr) * 1976-10-22 1978-05-19 Anvar Adjuvant immunologique constitue par le p-amino-phenyl de n-acetyl-muramyl-l-alanyl-d-isoglutamine
US4268505A (en) * 1978-04-13 1981-05-19 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition comprising a nitrogen-containing polysaccharide and an antibiotic agent, and a method of treating an infectious disease therewith
FI803077A7 (fi) * 1979-10-12 1981-04-13 Ciba Geigy Ag Foerfarande foer framstaellning av myramylpeptider

Also Published As

Publication number Publication date
ES493633A0 (es) 1981-07-01
NZ194432A (en) 1983-09-02
IE801533L (en) 1981-01-25
KR840001617B1 (ko) 1984-10-11
DK161025C (da) 1991-10-28
PL131613B1 (en) 1984-12-31
CS276965B6 (en) 1992-11-18
PT71607A (de) 1980-08-01
CA1183129A (en) 1985-02-26
PL225870A1 (cg-RX-API-DMAC10.html) 1981-05-08
FI802294A7 (fi) 1981-01-26
US4414204A (en) 1983-11-08
NO157177C (no) 1988-02-03
SG38187G (en) 1988-01-15
ZA804487B (en) 1981-07-29
HU188861B (en) 1986-05-28
HK85787A (en) 1987-11-27
ES8105971A1 (es) 1981-07-01
US4406890A (en) 1983-09-27
CY1381A (en) 1987-12-18
JPS6356239B2 (cg-RX-API-DMAC10.html) 1988-11-07
DK319480A (da) 1981-01-26
EP0025495B1 (de) 1984-06-20
SU1277906A3 (ru) 1986-12-15
AU6658181A (en) 1982-11-04
CS526280A3 (en) 1992-06-17
KR830003511A (ko) 1983-06-21
AU6078880A (en) 1981-01-29
FI75578C (fi) 1988-07-11
IL60676A0 (en) 1980-09-16
DE3068304D1 (en) 1984-07-26
JPS5649397A (en) 1981-05-02
NO157177B (no) 1987-10-26
PL127481B1 (en) 1983-10-31
IE50145B1 (en) 1986-02-19
FI75578B (fi) 1988-03-31
MX9203368A (es) 1992-09-01
MY8700554A (en) 1987-12-31
AU541147B2 (en) 1984-12-20
DD153843A5 (de) 1982-02-03
NO802200L (no) 1981-01-26
SU1277905A3 (ru) 1986-12-15
EP0025495A1 (de) 1981-03-25
IL60676A (en) 1984-10-31
DK161025B (da) 1991-05-21

Similar Documents

Publication Publication Date Title
BR8002583A (cg-RX-API-DMAC10.html)
BR8006808A (cg-RX-API-DMAC10.html)
AU78386S (cg-RX-API-DMAC10.html)
AU79557S (cg-RX-API-DMAC10.html)
AU78385S (cg-RX-API-DMAC10.html)
AU77669S (cg-RX-API-DMAC10.html)
AU78389S (cg-RX-API-DMAC10.html)
AU78390S (cg-RX-API-DMAC10.html)
AU78391S (cg-RX-API-DMAC10.html)
AU78569S (cg-RX-API-DMAC10.html)
AU79200S (cg-RX-API-DMAC10.html)
AU78271S (cg-RX-API-DMAC10.html)
AU79558S (cg-RX-API-DMAC10.html)
AU79826S (cg-RX-API-DMAC10.html)
AU79918S (cg-RX-API-DMAC10.html)
AU78270S (cg-RX-API-DMAC10.html)
AU77763S (cg-RX-API-DMAC10.html)
AU79950S (cg-RX-API-DMAC10.html)
AU80228S (cg-RX-API-DMAC10.html)
BR5901094U (cg-RX-API-DMAC10.html)
AU79559S (cg-RX-API-DMAC10.html)
PL225870A1 (cg-RX-API-DMAC10.html)
BG28730A1 (cg-RX-API-DMAC10.html)
BG28376A1 (cg-RX-API-DMAC10.html)
BE878260A (cg-RX-API-DMAC10.html)